CBLL

Ceribell, Inc.

Electromedical & Electrotherapeutic Apparatus · SIC 3845CIK 1861107Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$89.0M

Net Income FY2025

$(53.0M)

EPS (Basic, as reported)

$-1.46

Net Margin FY2025

-60.0%

ROE FY2025

-34.4%

Total Equity

$155.0M

Shares Out

38M

Business description

Ceribell, Inc. — Electromedical & Electrotherapeutic Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 45 → 89 +40.6% CAGR

Fiscal yearFY2023⚑FY2024⚑FY2025

Revenue456589

Cost of revenue(7)(9)(11)

Gross profit385778

Research & development(9)(14)(19)

Selling & marketing(39)(49)(73)

General & administrative(20)(34)(44)

Total operating expenses(68)(96)(137)

Operating income(30)(40)(58)

Interest expense(2)(2)(2)

Other income (expense), net337

Pre-tax income(29)(40)(53)

Income tax expense000

Net income(29)(40)(53)

EPS — basic($5.56)($3.39)($1.46)

EPS — diluted($5.56)($3.39)($1.46)

Shares outstanding — basic (M)51237

Shares outstanding — diluted (M)51237

⚑ Weighted-average shares changed ×2.40 between FY2023 and FY2024 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
⚑ Weighted-average shares changed ×3.08 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.